in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Vertellus upgrades Belgium facility for API niacin manufacture
7:23 AM MDT | May 3, 2013 | Deepti Ramesh
Vertellus Specialties (Indianapolis) says that its facility at Antwerp has completed capital and other upgrades for the manufacture of niacin, or nicotinic acid, for pharmaceutical use. The plant has been producing niacin and niacinamide for nearly 30 years and has supplied the ingredient for food applications as well as agricultural needs. Vertellus completed projects last year to upgrade the facility to meet stringent guidelines necessary to be fully compliant with cGMP in manufacture of an active pharmaceutical ingredient (API) and has been inspected and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee